Drug intelligence / Profile preview

Alutard SQ Felis domesticus

Development stage
Unknown
Lead developer
ALK Abelló
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intralymphatic
01

Overview

Alutard SQ Felis domesticus is a standardized allergen extract derived from the hair and dander of the domestic cat (*Felis domesticus*), specifically formulated for allergen immunotherapy (AIT). Developed by ALK-Abelló, it utilizes the Standardized Quality (SQ) system to ensure potency and consistency of the major allergen, Fel d 1. The product consists of allergens adsorbed onto aluminum hydroxide, which serves as an adjuvant to create a depot effect, facilitating the slow release of the allergen and reducing the risk of systemic allergic reactions. Its mechanism of action involves the induction of immune tolerance, shifting the immune response from a Th2-mediated allergic phenotype (associated with IgE production) to a Th1/Treg-mediated response (characterized by the production of allergen-specific IgG4 antibodies and the suppression of mast cell and basophil activation). It is primarily indicated for the treatment of patients with IgE-mediated allergic rhinitis and allergic asthma triggered by cat allergens. While traditionally administered via subcutaneous immunotherapy (SCIT), it is also being investigated for intralymphatic immunotherapy (ILIT) to potentially improve safety and reduce treatment duration.

Brand names
Alutard SQAlutard SQ Felis domesticus
Other names
Alutard SQ CatCat allergen extractFelis domesticus allergen extractStandardized allergen extract Felis domesticus

Beyond the preview

Go deeper on Alutard SQ Felis domesticus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alutard SQ Felis domesticus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call